01Core principlesThe concepts and mechanisms needed to understand the subject.
Neurosurgical patients can have strong thrombosis drivers: immobility, paresis, malignancy, long surgery, critical illness and previous VTE. The same patient may have catastrophic bleeding consequences within a closed cranial or spinal compartment. A safe plan names both risks and states when the balance will be reviewed.
Mechanical methods can begin without systemic anticoagulation when limb and skin conditions permit. Pharmacological prevention reduces VTE but depends on operation type and haemostasis. Cranial recommendations, elective spinal recommendations and nonsurgical spinal-injury recommendations are distinct; a remembered generic surgical time cannot replace the matching section.
Key points
- Reassess every patient’s VTE risk and bleeding risk on admission and whenever clinical condition, mobility, operation, bleeding or discharge plan changes.
- Use early mobilisation when safe and apply procedure-specific mechanical prophylaxis; confirm that stockings or compression devices fit, function and do not injure skin or compromise limbs.
- For cranial surgery, NICE says consider mechanical prophylaxis and conditional LMWH 24–48 hours postoperatively when VTE risk exceeds bleeding risk, continuing for at least seven days.
- Earlier-than-24-hour spinal LMWH is an exception based on senior multidisciplinary opinion or a locally agreed protocol, not a routine acceleration target.
- For elective spinal surgery, NICE offers mechanical prophylaxis on admission and considers LMWH when VTE risk exceeds bleeding risk, usually beginning 24–48 hours after surgery.
- These schedules apply to people over 16 and do not abolish surgeon judgement about haemostasis, intracranial or spinal bleeding, drains, emergency operations or a planned reoperation.
- Suspected DVT or PE is a diagnostic and treatment problem; prophylaxis doses are not treatment for confirmed thrombosis.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Previous VTE, active cancer, major immobility, paresis, thrombophilia, critical illness, long complex surgery and reduced baseline mobility increase the prevention benefit.
Active operative bleeding, evolving haematoma, coagulopathy, severe thrombocytopenia, unsecured haemostasis, neuraxial concerns or imminent reoperation can delay LMWH.
New unilateral swelling, pain, warmth or unexplained limb asymmetry requires a diagnostic DVT pathway rather than merely intensifying prophylaxis.
New unexplained dyspnoea, hypoxaemia, chest pain, tachycardia, haemoptysis, syncope or shock needs urgent objective assessment.
New cranial or spinal neurological deterioration after anticoagulant exposure requires immediate review of an operative-site bleed and senior neurosurgical involvement.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Documented VTE and bleeding risk assessment - Why
- Identify patient, operation, mobility and haemostasis factors and create an explicit prevention and reassessment plan.
- Interpretation and limitations
- The balance changes over time; a delayed LMWH decision should carry a review trigger rather than becoming an unexamined permanent omission.
- 02
Full blood count, renal function and coagulation studies when clinically indicated - Why
- Identify thrombocytopenia, renal accumulation risk, anaemia or coagulopathy relevant to prophylaxis selection and bleeding.
- Interpretation and limitations
- Normal tests do not prove surgical haemostasis, while an abnormal result must be interpreted with drug, operation and clinical findings.
- 03
Compression ultrasonography for suspected DVT - Why
- Assess venous compressibility and thrombosis in the symptomatic limb using the established diagnostic pathway.
- Interpretation and limitations
- A confirmed clot moves care from prevention to treatment; a negative study is interpreted with pretest probability and repeat-testing rules where applicable.
- 04
CT pulmonary angiography or alternative PE imaging - Why
- Confirm or exclude pulmonary embolism when clinical probability warrants imaging and renal or contrast factors are considered.
- Interpretation and limitations
- A positive result requires urgent joint treatment planning because recent cranial or spinal surgery may make standard anticoagulation hazardous.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked caseElective spinal surgery prophylaxisAn adult undergoes elective spine surgery and has no active bleeding or planned early reoperation.+
- 1Offer mechanical prophylaxis on admission using stockings or intermittent pneumatic compression, and reassess fit, skin, mobility, VTE risk and bleeding risk.
- 2When VTE risk outweighs bleeding risk, start LMWH 24–48 hours after surgery using clinical judgement about the patient and procedure; earlier use requires senior multidisciplinary or local-protocol support.
- 3Continue the elective spinal prevention plan for 30 days or until the person is mobile or discharged, whichever occurs sooner, while revising it if bleeding or thrombosis develops.
- 4Verify at discharge that prophylaxis duration, administration, mobility goals, bleeding warnings and VTE return symptoms are documented and understood.
02Cranial routeHaemostasis-dependent cranial preventionA person has cranial surgery and their VTE risk is judged against intracranial bleeding risk.+
- 1Consider mechanical prophylaxis and verify that the chosen method is safe for the limbs and skin.
- 2Consider LMWH 24–48 hours postoperatively when VTE risk exceeds bleeding risk and haemostasis is acceptable; continue for at least seven days.
- 3If bleeding risk prevents dosing, document the reason, maintain suitable mechanical prevention and specify the senior review point.
03Suspected eventDVT or PE despite preventionSymptoms suggest venous thrombosis or pulmonary embolism during the postoperative period.+
- 1Stabilise immediately if hypoxaemic or shocked and obtain objective imaging through the acute VTE pathway.
- 2Involve neurosurgery before therapeutic anticoagulation or thrombolysis decisions, because the operation and current imaging determine bleeding tolerance.
- 3After diagnosis, replace the prophylaxis plan with an individual treatment plan and monitor both neurological and cardiopulmonary status.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- Check mechanical-device placement, interruptions, skin and distal circulation each shift according to local policy and record why it is temporarily removed.
- Review mobility, VTE risk, bleeding, platelets and renal function at clinically relevant changes and before each pharmacological timing decision.
- After LMWH begins, watch for wound expansion, falling haemoglobin, new headache, focal deficit, back pain or spinal neurological change and escalate promptly.
- At discharge, state prophylaxis drug, dose, duration, administration support, missed-dose advice, bleeding signs and DVT or PE symptoms in the handover.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Balance is dynamic
A defensible plan records why thrombosis or bleeding dominates now and what finding will trigger another decision.
Mechanical needs care
Compression is active treatment that fails when removed, poorly fitted or causing pressure injury.
Operation determines rule
Elective spinal, cranial and nonsurgical spinal-injury recommendations have different timing and duration statements.
Diagnosis changes dose
Once DVT or PE is suspected, use diagnostic and treatment pathways rather than adjusting routine prophylaxis empirically.
07Common pitfallsFrequent interpretation and management errors.
- 01
Applying one timing rule to cranial and spinal surgery loses the distinct NICE durations and exception language.
- 02
Starting LMWH from the clock alone without reassessing haemostasis can turn prevention into a closed-compartment bleed.
- 03
Withholding pharmacological prophylaxis once and never reviewing the balance leaves immobilised high-risk patients unprotected.
- 04
Treating suspected PE with a prophylactic dose delays diagnosis and definitive management.